ArriVent BioPharma, Inc. - AVBP
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 17
Latest filed: Mar 17, 2026
| Form | Count |
|---|---|
| SCHEDULE 13G/A | 6 |
| 4 | 6 |
| 8-K | 3 |
| SCHEDULE 13G | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Mar 17, 2026 | 8-K | Mar 17, 2026 | 0001104659-26-029588 | View |
| Mar 05, 2026 | SCHEDULE 13G/A | — | 0001104659-26-023750 | View |
| Mar 05, 2026 | 8-K | Mar 05, 2026 | 0001104659-26-024112 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0000902664-26-001013 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0002058093-26-000004 | View |
| Feb 04, 2026 | 4 | Feb 02, 2026 | 0001104659-26-010471 | View |
| Feb 04, 2026 | 4 | Feb 02, 2026 | 0001104659-26-010472 | View |
| Feb 04, 2026 | 4 | Feb 02, 2026 | 0001104659-26-010473 | View |
| Feb 04, 2026 | 4 | Feb 02, 2026 | 0001104659-26-010477 | View |
| Feb 04, 2026 | 4 | Feb 02, 2026 | 0001104659-26-010478 | View |
| Feb 03, 2026 | 4 | Dec 10, 2025 | 0000902664-26-000675 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | — | 0000102909-26-000090 | View |
| Jan 21, 2026 | SCHEDULE 13G | — | 0002012383-26-000643 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | — | 0001214659-25-016716 | View |
| Nov 10, 2025 | 8-K | Nov 10, 2025 | 0001104659-25-108839 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | — | 0000315066-25-002677 | View |
| Oct 30, 2025 | SCHEDULE 13G | — | 0000102909-25-000025 | View |